Pages that link to "Q30224145"

The following pages link to US Military contributions to the global response to pandemic chikungunya (Q30224145):

Displaying 29 items.

• Chikungunya: epidemiology (Q24701719) (← links)
• DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice (Q24701765) (← links)
• Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate (Q26314495) (← links)
• Chikungunya vaccines in development (Q26700081) (← links)
• Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity (Q28550385) (← links)
• Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen (Q28599242) (← links)
• Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies (Q30235512) (← links)
• Next generation sequencing of DNA-launched Chikungunya vaccine virus. (Q30384231) (← links)
• Seroprevalence of antibodies to dengue and chikungunya viruses in Thailand (Q33853736) (← links)
• Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design (Q35109218) (← links)
• Do we need a vaccine against chikungunya? (Q35933249) (← links)
• Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus (Q37711813) (← links)
• Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy (Q38118022) (← links)
• Self-replicating alphavirus RNA vaccines. (Q38255634) (← links)
• A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization (Q38329445) (← links)
• Isolation of Premyrsinane, Myrsinane, and Tigliane Diterpenoids from Euphorbia pithyusa Using a Chikungunya Virus Cell-Based Assay and Analogue Annotation by Molecular Networking (Q38696766) (← links)
• Chikungunya fever: an emerging viral infection threatening North America and Europe (Q38964360) (← links)
• Regulatory considerations in development of vaccines to prevent disease caused by Chikungunya virus (Q40045437) (← links)
• Fighting back against chikungunya (Q40166831) (← links)
• Deinococcus Mn2+-peptide complex: A novel approach to alphavirus vaccine development (Q40174800) (← links)
• Can understanding the virulence mechanisms of RNA viruses lead us to a vaccine against eastern equine encephalitis virus and other alphaviruses? (Q41965736) (← links)
• Chikungunya virus control: is a vaccine on the horizon? (Q42199384) (← links)
• Vaccine and Therapeutic Options To Control Chikungunya Virus (Q47566099) (← links)
• The US Military Commitment to Vaccine Development: A Century of Successes and Challenges. (Q55432397) (← links)
• Recent development in the strategies projected for chikungunya vaccine in humans (Q60045750) (← links)
• Chikungunya infection: de-linking replication from symptomatology reveals the central role of muscle (Q89626909) (← links)
• Chikungunya Virus Infections in Military Deployments in Tropical Settings-A Narrative Minireview (Q92733060) (← links)
• Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections (Q94561515) (← links)
• Infectious RNA vaccine protects mice against chikungunya virus infection (Q104064453) (← links)